SCHEMBL23809174

SCHEMBL23809174

Cc1c(C(=O)O)n(C)c2c(C(C)C)cccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.45
PTGES2 Q9H7Z7 1/20 0.44
GPR35 Q9HC97 1/20 0.40
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GRM4 Q14833 1/20 0.37
NOTUM Q6P988 1/20 0.36
TSHR P16473 2/20 0.36
FABP4 P15090 1/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
ATM Q13315 1/20 0.35
MEN1 O00255 2/20 0.35
FAAH O00519 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
GABRA1 P14867 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28064638 0.78 MCL1 (0.47) MCL1GPR35KDM4EL3MBTL1TSHR
SCHEMBL28064659 0.78 MCL1 (0.50) MCL1GPR35KDM4EL3MBTL1NOTUM
SCHEMBL14931059 0.74 GABRA1 (0.44) PTGES2L3MBTL1GRM4TSHRLMNA
SCHEMBL26037786 0.71 CYP19A1 (0.38) GPR35KDM4EL3MBTL1TSHRKMT2A
SCHEMBL23809344 0.71 NOTUM (0.40) MCL1PTGES2KDM4EL3MBTL1NOTUM
SCHEMBL1092586 0.70 KDM4E (0.67) MCL1KDM4EL3MBTL1TSHRKMT2A
SCHEMBL30639179 0.70 KDM4E (0.67) MCL1KDM4EL3MBTL1TSHRKMT2A
SCHEMBL23809304 0.70 RARA (0.37) KDM4EL3MBTL1NOTUMTSHRKMT2A
SCHEMBL23809303 0.70 KDM4E (0.40) PTGES2KDM4ETSHRKMT2ALMNA
SCHEMBL28792536 0.69 HTR2C (0.47) MCL1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MCL1 1/4885PTGES2 2573/4885GPR35 3148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.